28063948|t|Cytokine IL-10, activators of PI3-kinase, agonists of α-2 adrenoreceptor and antioxidants prevent ischemia - induced cell death in rat hippocampal cultures
28063948|a|In the present work we compared the protective effect of anti-inflammatory cytokine IL-10 with the action of a PI3-kinase selective activator 740 Y-P, selective agonists of alpha-2 adrenoreceptor, guanfacine and UK-14,304, and compounds having antioxidant effect: recombinant human peroxiredoxin 6 and B27, in hippocampal cell culture during OGD (ischemia-like conditions). It has been shown that the response of cells to OGD in the control includes two phases. The first phase was accompanied by an increase in the frequency of spontaneous synchronous Ca(2+)-oscillations (SSCO) in neurons and Ca(2+) - pulse in astrocytes. Spontaneous Ca(2+) events in astrocytes during ischemia in control experiments disappeared. The second phase started after a few minutes of OGD and looked like a sharp/avalanche, global synchronic (within 20 s) increase in [Ca(2+)]i in many cells. Within 1 h after OGD, a mass death of cells, primarily astrocytes, was observed. To study the protective action of the compounds, cells were incubated in the presence of the neuroprotective agents for 10-40 min or 24 h before ischemia. All the neuroprotective agents delayed a global [Ca(2+)]i increase during OGD or completely inhibited this process and increased cell survival.
28063948	0	8	Cytokine	T103	UMLS:C0079189
28063948	9	14	IL-10	T103	UMLS:C0085295
28063948	16	26	activators	T103	UMLS:C0751968
28063948	30	40	PI3-kinase	T103	UMLS:C0044602
28063948	42	50	agonists	T103	UMLS:C0243192
28063948	54	72	α-2 adrenoreceptor	T103	UMLS:C0034783
28063948	77	89	antioxidants	T103	UMLS:C0003402
28063948	98	106	ischemia	T038	UMLS:C0022116
28063948	117	127	cell death	T038	UMLS:C0007587
28063948	131	134	rat	T204	UMLS:C0034693
28063948	135	146	hippocampal	T017	UMLS:C0019564
28063948	231	239	cytokine	T103	UMLS:C0079189
28063948	240	245	IL-10	T103	UMLS:C0085295
28063948	267	277	PI3-kinase	T103	UMLS:C0044602
28063948	278	297	selective activator	T103	UMLS:C0751968
28063948	298	305	740 Y-P	T103	UMLS:C1254351
28063948	307	325	selective agonists	T103	UMLS:C0243192
28063948	329	351	alpha-2 adrenoreceptor	T103	UMLS:C0034783
28063948	353	363	guanfacine	T103	UMLS:C0079466
28063948	368	377	UK-14,304	T103	UMLS:C0147760
28063948	383	392	compounds	T103	UMLS:C1254351
28063948	400	418	antioxidant effect	T038	UMLS:C3179302
28063948	432	453	human peroxiredoxin 6	T103	UMLS:C1873178
28063948	458	461	B27	T103	UMLS:C1254351
28063948	466	477	hippocampal	T017	UMLS:C0019564
28063948	491	501	during OGD	T038	UMLS:C4236780
28063948	557	581	response of cells to OGD	T038	UMLS:C4236780
28063948	685	728	spontaneous synchronous Ca(2+)-oscillations	T038	UMLS:C0600430
28063948	730	734	SSCO	T038	UMLS:C0600430
28063948	739	746	neurons	T017	UMLS:C0027882
28063948	751	757	Ca(2+)	T103	UMLS:C0596235
28063948	760	765	pulse	T038	UMLS:C0391850
28063948	769	779	astrocytes	T017	UMLS:C0004112
28063948	793	799	Ca(2+)	T103	UMLS:C0596235
28063948	810	820	astrocytes	T017	UMLS:C0004112
28063948	828	836	ischemia	T038	UMLS:C0022116
28063948	860	871	disappeared	T033	UMLS:C0243095
28063948	898	924	after a few minutes of OGD	T038	UMLS:C4236780
28063948	943	958	sharp/avalanche	T033	UMLS:C0243095
28063948	960	977	global synchronic	T033	UMLS:C0243095
28063948	1005	1011	Ca(2+)	T103	UMLS:C0596235
28063948	1022	1027	cells	T017	UMLS:C0007634
28063948	1040	1049	after OGD	T038	UMLS:C4236780
28063948	1053	1072	mass death of cells	T038	UMLS:C0007587
28063948	1084	1094	astrocytes	T017	UMLS:C0004112
28063948	1148	1157	compounds	T103	UMLS:C1254351
28063948	1159	1164	cells	T017	UMLS:C0007634
28063948	1170	1179	incubated	T058	UMLS:C1439852
28063948	1203	1225	neuroprotective agents	T103	UMLS:C0242912
28063948	1255	1263	ischemia	T038	UMLS:C0022116
28063948	1273	1295	neuroprotective agents	T103	UMLS:C0242912
28063948	1314	1320	Ca(2+)	T103	UMLS:C0596235
28063948	1332	1342	during OGD	T038	UMLS:C4236780
28063948	1394	1407	cell survival	T038	UMLS:C0007620